Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.

A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

Here is some of what you may have missed from the world's largest cancer research meeting.

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.

ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.

Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.

The Trump administration has released a sweeping proposal to overhaul the bedrock regulation for all federal grants.

A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step," researcher says.

Kyle Diamantas doesn't have the typical CV for an FDA commissioner, but he's earning early praise.

Besides showing skepticism on the budget, senators grilled the NIH director about a leadership vacuum, two viral outbreaks, and the pace of funding.

A UCSF team has submitted an application to the FDA seeking approval for a small trial of in utero gene therapy for a rare lysosomal storage disorder.

Growing evidence suggests it takes a sustained viral infection in the right genetic environment to lead to type 1 diabetes.

“Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record of science, a new study found

Most researchers conduct their more disruptive work early in their careers, but as they age, they tend to abandon that groundbreaking energy

An international team has found thousands of mini-proteins, including some involved in cell division and DNA repair, as well as several unique to cancer cells.

Labs are seeing fewer applications from international students and researchers, and some doctoral students are considering leaving early.

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized information machine, died at 79.

The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of tactics to try to obtain funding

The charges against Morens come after Congressional probes related to the origins of the virus that causes Covid-19.

Fewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.

The problematic use of guest editors was spotlighted last week when a genetics journal retracted nearly an entire special issue.

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to cancers

A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond.

Lawmakers seem poised to reject cuts to biomedical research and public health spending for a second straight year.

A CAR-T trial shows promise in preventing smoldering multiple myeloma from becoming the real thing.

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell therapy.

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't actually necessary to achieve effective weight loss.

A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma patients.

The researchers identified a driving force behind the condition, opening up a potential target for new therapies.